Related references
Note: Only part of the references are listed.Neutrophil extracellular traps may have a dual role inPseudomonas aeruginosakeratitis
Binbin Zhu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
A pipeline to evaluate inhibitors of the Pseudomonas aeruginosa exotoxin U
Daniel M. Foulkes et al.
BIOCHEMICAL JOURNAL (2021)
Pseudomonas aeruginosa survives in epithelia by ExoS-mediated inhibition of autophagy and mTOR
Lang Rao et al.
EMBO REPORTS (2021)
Persistent Bacterial Coinfection of a COVID-19 Patient Caused by a Genetically Adapted Pseudomonas aeruginosa Chronic Colonizer
Jiuxin Qu et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Pseudomonas aeruginosa and microbial keratitis
Yasmin Hilliam et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2020)
Co-infections in people with COVID-19: a systematic review and meta-analysis
Louise Lansbury et al.
JOURNAL OF INFECTION (2020)
Evaluation of Guideline Recommendations for Dual Antipseudomonal Therapy in Hospitalized Adults with Pneumonia Using Combination Antibiograms
Quyen Luu et al.
PHARMACOTHERAPY (2020)
Acquired fluoroquinolone resistance genes in corneal isolates of Pseudomonas aeruginosa
Mahjabeen Khan et al.
INFECTION GENETICS AND EVOLUTION (2020)
Fitting Pieces into the Puzzle of Pseudomonas aeruginosa Type III Secretion System Gene Expression
Emily A. Williams McMackin et al.
JOURNAL OF BACTERIOLOGY (2019)
The effect of the sub-minimal inhibitory concentration and the concentrations within resistant mutation window of ciprofloxacin on MIC, swimming motility and biofilm formation of Pseudomonas aeruginosa
Nan Shi et al.
MICROBIAL PATHOGENESIS (2019)
Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial Infections
Daniel M. Foulkes et al.
MICROORGANISMS (2019)
The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis
Rajiv Dhand
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
The Impact of ExoS on Pseudomonas aeruginosa Internalization by Epithelial Cells Is Independent of fleQ and Correlates with Bistability of Type Three Secretion System Gene Expression
Abby R. Kroken et al.
MBIO (2018)
Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media
Min-Hyun Park et al.
AURIS NASUS LARYNX (2017)
The effect of clindamycin and amoxicillin on neutrophil extracellular trap (NET) release
Weronika Bystrzycka et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Correlation of Pseudomonas aeruginosa Genotype With Antibiotic Susceptibility and Clinical Features of Induced Central Keratitis
Elizabeth P. Shen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Central role of PAFR signalling in ExoU-induced NF-κB activation
Carolina Diettrich Mallet de Lima et al.
CELLULAR MICROBIOLOGY (2014)
Pseudomonas aeruginosa Utilizes the Type III Secreted Toxin ExoS to Avoid Acidified Compartments within Epithelial Cells
Susan R. Heimer et al.
PLOS ONE (2013)
Subinhibitory Concentration of Kanamycin Induces the Pseudomonas aeruginosa type VI Secretion System
Cerith Jones et al.
PLOS ONE (2013)
Clinical outcomes of type III Pseudomonas aeruginosa bacteremia
Ali A. El-Solh et al.
CRITICAL CARE MEDICINE (2012)
Structure and Function of the Type III Secretion System of Pseudomonas aeruginosa
Marlies Galle et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2012)
ExoU Activates NF-κB and Increases IL-8/KC Secretion during Pseudomonas aeruginosa Infection
Carolina Diettrich Mallet de Lima et al.
PLOS ONE (2012)
Genetic Characterization Indicates that a Specific Subpopulation of Pseudomonas aeruginosa Is Associated with Keratitis Infections
Rosalind M. K. Stewart et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Pseudomonas aeruginosa Cytotoxin ExoU Is Injected into Phagocytic Cells during Acute Pneumonia
Maureen H. Diaz et al.
INFECTION AND IMMUNITY (2010)
ExsD Inhibits Expression of the Pseudomonas aeruginosa Type III Secretion System by Disrupting ExsA Self-Association and DNA Binding Activity
Evan D. Brutinel et al.
JOURNAL OF BACTERIOLOGY (2010)
Mechanism of action of and resistance to quinolones
Anna Fabrega et al.
MICROBIAL BIOTECHNOLOGY (2009)
Pseudomonas aeruginosa induces localized immunosuppression during pneumonia
Maureen H. Diaz et al.
INFECTION AND IMMUNITY (2008)
Prevalence of Type III Secretion Protein Exoenzymes and Antimicrobial Susceptibility Patterns from Bloodstream Isolates of Patients with Pseudomonas aeruginosa Bacteremia
K. W. Garey et al.
JOURNAL OF CHEMOTHERAPY (2008)
The type III secretion system tip complex and translocon
C. A. Mueller et al.
MOLECULAR MICROBIOLOGY (2008)
Antibiotics as intermicrobial signaling agents instead of weapons
J. F. Linares et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production
Alayne Cuzick et al.
INFECTION AND IMMUNITY (2006)
Microbial keratitis - Predisposing factors and morbidity
L Keay et al.
OPHTHALMOLOGY (2006)
PscF is a major component of the Pseudomonas aeruginosa type III secretion needle
A Pastor et al.
FEMS MICROBIOLOGY LETTERS (2005)
Factors triggering type III secretion in Pseudomonas aeruginosa
J Kim et al.
MICROBIOLOGY-SGM (2005)
Aminoglycoside antibiotics induce bacterial biofilm formation
LR Hoffman et al.
NATURE (2005)
Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1
S Bleves et al.
JOURNAL OF BACTERIOLOGY (2005)
Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia
GS Schulert et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa
AR Hauser et al.
CRITICAL CARE MEDICINE (2002)
Independent and coordinate effects of ADP-ribosyltransferase and GTPase-activating activities of exoenzyme S on HT-29 epithelial cell function
JE Fraylick et al.
INFECTION AND IMMUNITY (2001)
Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections
A Roy-Burman et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Resistance of Pseudomonas aeruginosa isolates to hydrogel contact lens disinfection correlates with cytotoxic activity
C Lakkis et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
